Anti-inflammatory approaches to ischaemic stroke prevention.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28935831.
- Also identified by DOI 10.1136/jnnp-2016-314817.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stroke is a major cause of neurological morbidity and mortality. Atherosclerosis is a major contributor to first and recurrent stroke. A growing evidence base indicates that inflammation is a key process in the pathogenesis of atherosclerosis, leading to thromboembolic events. In this review, we summarise the evidence linking inflammation to stroke risk and discuss clinical trials addressing the 'inflammation hypothesis' in coronary disease and stroke. <b>Trial registration number</b> CONVINCE trial ClinicalTrials.gov number; NCT 02898610; Pre-results.
Medical subject headings
- Brain Ischemia
- Inflammation
- Intracranial Arteriosclerosis
- Stroke